Riskpilot← Back to searchSign inGet full accessSweBangla AB
ABActiveOrg 5569999864Husbytorpsvägen 27General medical practice activities · NACE 8621Est. 20151 employees
Revenue 2024
SEK 178K
-67% vs 2023
EBITDA margin
26.1%
-79% vs 2023
Equity ratio
59.8%
Financial strength
Net profit 2024
SEK 2M
+155% vs 2023
| Revenue | SEK 178K | -67% |
| EBITDA | SEK 47K | -79% |
| Net profit | SEK 2M | +155% |
| Total assets | SEK 15,1M | +38% |
| Equity | SEK 9M | +21% |
| Employees | 1 | — |
Legal name
SweBangla AB
Org number
5569999864
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
12 januari 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är bedriva läkarverksamhet, bedriva försäljning och förmedling av produkter inom hälsa och hälsovård, tjänster, konsultation och utbildning inom hälsa och hälsovård samt därmed förenlig verksamhet. Vidare bedriva handel och förvaltning av värdepapper och fastigheter och därmed förenlig verksamhet.
Address
Husbytorpsvägen 27
Email
docshetu@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 2 996 | 2 789 | 5 518 | 11 203 | 11 431 | 538 | 178 |
| Staff expenses | — | — | — | — | — | — | — | −2 154 | −0 | −0 |
| EBITDA | −3 | 1 071 | 1 561 | 1 237 | 1 070 | 1 343 | 3 266 | 4 055 | 224 | 47 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −2 | −8 | −8 | −8 |
| EBIT | −3 | 1 071 | 1 561 | 1 237 | 1 070 | 1 343 | 3 264 | 4 048 | 216 | 39 |
| Net financials | — | −1 | −4 | −1 | −2 | −1 | — | −0 | 387 | 1 733 |
| Profit before tax | −3 | 802 | 1 167 | 924 | 797 | 1 004 | 2 463 | 3 235 | 992 | 2 083 |
| Tax | −0 | −177 | −257 | −205 | −173 | −217 | −510 | −674 | −223 | −121 |
| Net profit | −3 | 625 | 910 | 719 | 624 | 787 | 1 953 | 2 561 | 770 | 1 961 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 50 | 1 024 | 2 443 | 3 633 | 4 494 | 5 183 | 8 544 | 12 366 | 10 980 | 15 127 |
| Equity | 47 | 672 | 1 584 | 2 303 | 2 926 | 3 213 | 4 667 | 6 728 | 7 497 | 9 049 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | 3 228 |
| Short-term debt | 3 | 83 | 202 | 362 | 329 | 393 | 1 500 | 2 449 | 684 | 362 |
| Total debt | 3 | 83 | 202 | 362 | 329 | 393 | 1 500 | 2 449 | 684 | 3 590 |
EBITDA margin
26.1%
This company
15.8%
Market median
+65% vs market
20152024
Equity ratio
59.8%
This company
38.2%
Market median
+57% vs market
20152024
Return on equity
21.7%
This company
18.4%
Market median
+18% vs market
20152024
Net profit margin
1100.5%
This company
8.1%
Market median
+13486% vs market
20152024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20152024
Debt / equity
0.67×
This company
0.62×
Market median
+8% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SweBangla AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohammad Faizul Islam | Board of Directors | 0 companies |
| Faria Islam | Deputy Board Member | 0 companies |